Tulobuterol
Top View
- Overview of Algorithms to Be Used for Detecting COPD, COPD Exacerbations and Pneumonia
- Clinical Benefit of Two-Times-Per-Day Aclidinium Bromide Compared with Once-A-Day Tiotropium Bromide Hydrate in COPD: a Multicentre, Open-Label, Randomised Study
- Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- Statistical Analysis Plan
- (12) United States Patent (10) Patent No.: US 8,506,935 B2 Hale Et Al
- Allergology International Vol.54 No.4
- Disease Area Drug Class/Mechanism Year of Launch
- Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
- ICS) and Long-Acting Beta-Agonists (Labas
- Review of the Square Box Symbol Uses
- Efficacy of Salmeterol and Formoterol Combination Treatment in Mice with Chronic Obstructive Pulmonary Disease
- THE NDAC (Pulmonary) HELD on 03.12.2011
- Effects of Transdermal Tulobuterol on Dyspnea and Respiratory Function During Exercise in Patients with Chronic Obstructive Pulmonary Disease
- Wo 2007/044693 A2
- Aclidinium Bromide Drug Utilisation Post-Authorisation Safety Study
- PASS Information
- FINAL REPORT Comparative Safety and Effectiveness of Long-Acting
- WALLET CARD2021 Examples of Prohibited and Permitted Substances and Methods Effective Jan